Solventum
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q4).
- Total institutional ownership rose 0.1 percentage points.
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 93.56% +0.12pp
- Institutions
- 1,051 -2
- As of
- 2026/Q4 vs. prior period
Holder types
Top holders as of 2026-03-19
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 42 buys · 8 sells
| Name | Role | Stake |
|---|---|---|
| 3M Company | -- | 15.06% |
| Bryan Hanson | Chief Executive Officer | 0.11% |
| Wayde McMillan | Chief Financial Officer | 0.03% |
| Amy Landucci | Chief Information & Digital Officer | 0.02% |
| Paul Harrington | Former Chief Supply Chain Officer | 0.01% |
| Carrie Cox | Independent Chairperson | 0.01% |
| Marcela Kirberger | Chief Corporate & Legal Affairs Officer & Corporate Secretary | 0.01% |
| Tammy Gomez | Chief Human Resources Officer | 0.01% |
| Amy McBride-Wendell | Independent Director | 0.01% |
| James Barry | Former Executive VP & Group President of Medical Surgical | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-31 | Bryan Hanson | Chief Executive Officer | Derivative Exercise and Sale | -26,468 | $90.95 |
| 2026-08-31 | Bryan Hanson | Chief Executive Officer | Derivative Exercise and Retained | +40,793 | -- |
| 2026-08-16 | Neil Zieselman | Chief Accounting Officer | Other Derivative Acquisition | +6,911 | -- |
| 2026-05-14 | Carrie Cox | Independent Chairperson | Other Derivative Acquisition | +4,848 | -- |
| 2026-05-14 | John Weiland | Independent Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Karen May | Independent Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Amy McBride-Wendell | Independent Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Glenn Eisenberg | Independent Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Bernard Harris | Independent Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Susan DeVore | Independent Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Carlos Alban | Independent Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Darryl Wilson | Independent Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Elizabeth Mily | Independent Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-14 | Shirley Edwards | Independent Director | Other Derivative Acquisition | +3,300 | -- |
| 2026-05-12 | Wayde McMillan | Chief Financial Officer | Derivative Exercise and Sale | -4,404 | $74.41 |
| 2026-05-12 | Wayde McMillan | Chief Financial Officer | Derivative Exercise and Retained | +5,099 | -- |
| 2026-05-12 | Bryan Hanson | Chief Executive Officer | Derivative Exercise and Sale | -13,503 | $74.41 |
| 2026-05-12 | Bryan Hanson | Chief Executive Officer | Derivative Exercise and Retained | +20,812 | -- |
| 2026-05-12 | Marcela Kirberger | Chief Corporate & Legal Affairs Officer & Corporate Secretary | Derivative Exercise and Sale | -1,952 | $74.41 |
| 2026-05-12 | Marcela Kirberger | Chief Corporate & Legal Affairs Officer & Corporate Secretary | Derivative Exercise and Retained | +2,536 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:28 · For reference only, not investment advice and not tailored to your situation.
Solventum discussion 0 comments